Passage Bio Common Stock share price logo

Passage Bio Common Stock

NASDAQ: PASG

Small Cap

$5.92

-0.20

(-3.27%)

Live

as on

Passage Bio Common Stock Stock Performance

as on June 25, 2026 at 4:22 am IST

  • Day's Low

    Day's High

    $5.78
    $6.30
    downward going graph

    2.36%

    Downside

    6.42%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.94
    $20.00
    downward going graph

    33.53%

    Downside

    237.84%

    Upside

    downward going graph

Passage Bio Common Stock share price movements today

Previous Close
$6.12
Open
$6.27
Volume
130.1K
Day's Low - High
$5.78 - $6.30
52 Week Low - High
$3.94 - $20.00

Passage Bio Common Stock Historical Returns

1 Month Return
+ 17.13 %
3 Month Return
-8.52 %
1 Year Return
-12.97 %
3 Year Return
-63.13 %
5 Year Return
-97.88 %

Passage Bio Common Stock Stock Fundamentals & Key Indicators

Check Passage Bio Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$18.3M

EPS (TTM)

-10.8533

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-36.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-128.90%

Passage Bio Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Passage Bio Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$18.3M-97.88%NA0.00%NA
BUY$38.2B65.93%71.9612.55%NA
BUY$118.5B144.05%27.735.51%NA
BUY$64.2B13.51%14.9529.65%0.59%

Stock Returns calculator for Passage Bio Common Stock Stock including INR - Dollar returns

The Passage Bio Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Passage Bio Common Stock investment value today

Current value as on today

₹92,756

Returns

-₹7,244

(-7.24%)

Returns from Passage Bio Common Stock Stock

-₹15,789 (-15.79%)

Dollar Impact

₹8,546 (+8.55%)

Analyst Recommendation on Passage Bio Common Stock Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Passage Bio Common Stock. Average target price of $12.67

Passage Bio Common Stock Share Price Target

Get share price movements and forecasts by analysts on Passage Bio Common Stock.

What analysts predicted

53.28%UPSIDE

Target Price

$12.67

Current Price

$5.92

Analyzed by

11 Analysts

Target

$12.67

Passage Bio Common Stock target price $12.67, a slight upside of 53.28% compared to current price of $5.92. According to 11 analysts rating.

Indian Investors' Interest in Passage Bio Common Stock Stock

Search interest for Passage Bio Common Stock Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-40% versus previous 30 day period

Passage Bio Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
5
-
-
-
3
-
-
-
-
-
Gross Profit
5
0
0
0
0
0
0
-
0
0
Operating Income
-18
-18
-17
-20
-14
-16
-10
-8
-13
-8
EBITDA
-14
-15
-16
-15
-12
-13
-9
-7
-10
-7
Interest Expense
1
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-16
-15
-19
-12
-15
-9
-7
-12
-7
Income Tax Expense
3
0
-
-
-
-
-
-
-
-
Net Income
-16
-16
-15
-19
-12
-15
-9
-7
-12
-7
Net Profit Margin
-283.46%
0.00%
0.00%
0.00%
-396.17%
0.00%
0.00%
0.00%
0.00%
0.00%

Passage Bio Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
-1
-3
-3
-3
0
Operating Income
-13
-37
-112
-185
-138
-100
-70
-43
EBITDA
-7
-36
-111
-176
-131
-98
-62
-44
Interest Expense
0
8
0
0
2
-
-
-
Depreciation
-
0
0
1
3
3
3
0
Income Before Tax
-12
-45
-112
-185
-136
-102
-64
-45
Income Tax Expense
0
8
0
6
0
5
0
-
Net Income
-12
-45
-112
-185
-136
-102
-64
-45
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Passage Bio Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-16
-15
-19
-12
-15
-9
-7
-12
-7
Operating Cash Flow
-18
-13
-7
-8
-13
-6
-4
-6
-12
Investing Cash Flow
25
1
14
13
39
0
-
1
0
Financing Cash Flow
8
0
-
0
-
0
-
0
-
Change in Cash
15
-12
7
5
25
-5
-4
-6
-12

Passage Bio Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-45
-112
-185
-136
-102
-64
-45
Operating Cash Flow
-39
-80
-126
-118
-78
-47
-31
Investing Cash Flow
-1
-172
-45
25
65
54
40
Financing Cash Flow
175
228
166
-1
0
8
0
Change in Cash
134
-23
-6
-94
-12
15
8

Global Institutional Holdings in Passage Bio Common Stock

Funds
Holdings
Vanguard Group Inc
3.95%
Ikarian Capital, LLC
2.12%
Squarepoint Ops LLC
0.34%
Millennium Management LLC
0.21%
Eversept Partners, LP
4.1%

Insights on Passage Bio Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PASG stock has moved up by 14.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.3% return, outperforming this stock by 31.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Passage Bio, Inc. Common Stock has experienced a drawdown of -63.1%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 42.4%

About Passage Bio Common Stock

Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; and PBKR03, for the treatment of Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other programs for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
OrganisationPassage Bio Common Stock
HeadquartersOne Commerce Square, Philadelphia, PA, United States, 19103
IndustryBiotechnology
CEODr. William Chou M.D.
E-voting on sharesClick here to vote

Key Management of Passage Bio Common Stock

Name

Title

Dr. William Chou M.D.

President, CEO & Director

Ms. Kathleen Borthwick

Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer

Mr. Stuart M. Henderson

Chief Business Officer

FAQs

What is Passage Bio Common Stock share price today?

Passage Bio Common Stock share price today is $5.92 as on . Passage Bio Common Stock share today touched a day high of $6.3 and a low of $5.78.

What is the 52 week high and 52 week low for Passage Bio Common Stock share?

Passage Bio Common Stock share touched a 52 week high of $20 on and a 52 week low of $3.94 on . Passage Bio Common Stock stock price today i.e. is trending at $5.92,which is 70.40% down from its 52 week high and 50.44% up from its 52 week low.

What is Passage Bio Common Stock's market capitalisation today?

Passage Bio Common Stock market capitalisation is $0.00T as on .

How to invest in Passage Bio Common Stock Stock (PASG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Passage Bio Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Passage Bio Common Stock Shares that will get you 0.2534 shares as per Passage Bio Common Stock share price of $5.92 per share as on June 24, 2026 at 10:52 pm IST.

What is the minimum amount required to buy Passage Bio Common Stock Stock (PASG) from India?

Indian investors can start investing in Passage Bio Common Stock (PASG) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in Passage Bio Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Passage Bio Common Stock share’s latest price of $5.92 as on June 24, 2026 at 10:52 pm IST, you will get 1.6892 shares of Passage Bio Common Stock. Learn more about fractional shares .

What are the returns that Passage Bio Common Stock has given to Indian investors in the last 5 years?

Passage Bio Common Stock stock has given -97.88% share price returns and 27.62% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?